{"retracted":true,"timestamp":1294099200000,"update":{"timestamp":null,"doi":null,"pmid":23211971,"type":"retraction"},"doi":"10.1038/sj.bjc.6605972","journal":"British journal of cancer","publisher":null,"title":"Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab."}
